Spots Global Cancer Trial Database for peripheral blood stem cell transplant
Every month we try and update this database with for peripheral blood stem cell transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies | NCT01203722 | Hematologic Mal... | Fludarabine Cytoxan Total Body Irra... Allogeneic Bloo... Peripheral Bloo... Mycophenolate M... Sirolimus Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant | NCT03961919 | Acute Myeloid L... Myelodysplastic... Transplant-Rela... | Fludarabine ARA-C Treosulfan Peripheral Bloo... | 65 Years - | IRCCS San Raffaele | |
| Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients | NCT01121120 | Lymphoma, Non-H... Hodgkin Disease Multiple Myelom... | TXA127 Placebo | 18 Years - | Tarix Pharmaceuticals | |
| Peripheral Blood Stem Cell Transplant (PBSCT) in Children With High Risk or Recurrent Solid Tumors | NCT00966498 | High Risk Solid... Recurrent Solid... | Peripheral Bloo... | - 35 Years | Emory University | |
| Chemotherapy Toxicity Reduction Via Urea Cycle Support | NCT00223730 | Cancer | Citrulline Placebo | 13 Years - 65 Years | Vanderbilt University | |
| Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies | NCT01203722 | Hematologic Mal... | Fludarabine Cytoxan Total Body Irra... Allogeneic Bloo... Peripheral Bloo... Mycophenolate M... Sirolimus Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma | NCT00427765 | Multiple Myelom... Lymphoma | Busulfan Melphalan | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant | NCT00048464 | Multiple Myelom... | Infusion of Act... | 18 Years - 70 Years | Xcyte Therapies | |
| Chemotherapy Toxicity Reduction Via Urea Cycle Support | NCT00223730 | Cancer | Citrulline Placebo | 13 Years - 65 Years | Vanderbilt University | |
| Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma | NCT00574626 | Lymphoma | PBSCT Bone Marrow Tra... | 16 Years - 65 Years | University of Nebraska | |
| Therapy for Children With Advanced Stage High Risk Neuroblastoma | NCT00186849 | Neuroblastoma | Topotecan, Cycl... Peripheral Bloo... | - 18 Years | St. Jude Children's Research Hospital | |
| Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases | NCT01336712 | Chronic Leukemi... Acute Leukemia Hodgkin's Disea... Non-Hodgkin's L... Myelodysplastic... | Peripheral Bloo... | 18 Years - 60 Years | Northside Hospital, Inc. | |
| Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant | NCT03961919 | Acute Myeloid L... Myelodysplastic... Transplant-Rela... | Fludarabine ARA-C Treosulfan Peripheral Bloo... | 65 Years - | IRCCS San Raffaele | |
| Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies | NCT01203722 | Hematologic Mal... | Fludarabine Cytoxan Total Body Irra... Allogeneic Bloo... Peripheral Bloo... Mycophenolate M... Sirolimus Tacrolimus | 6 Months - 75 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Therapy for Children With Advanced Stage High Risk Neuroblastoma | NCT00186849 | Neuroblastoma | Topotecan, Cycl... Peripheral Bloo... | - 18 Years | St. Jude Children's Research Hospital | |
| Allo HSCT Using RIC and PTCy for Hematological Diseases | NCT05805605 | Acute Myelogeno... Acute Lymphocyt... Biphenotypic Ac... Undifferentiate... Prolymphocytic ... Chronic Myeloge... Plasma Cell Leu... Myelodysplastic... Leukemia, Myelo... Myelodysplastic... Burkitt Lymphom... Relapsed T-Cell... Relapsed Chroni... Small Lymphocyt... Marginal Zone L... Follicular Lymp... Myeloproliferat... Myelofibrosis | Peripheral Bloo... Allopurinol 300... Fludarabine Cyclophosphamid... Bone Marrow Cel... Total Body Irra... Sirolimus Pill Mycophenolate M... | - 75 Years | Masonic Cancer Center, University of Minnesota |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
